An article in The Wall Street Journal (£) reports that for years, the healthcare industry has been looking into the potential of using synthetic data produced by artificial intelligence algorithms from real data sets. In theory, the technology would allow drug and health researchers to analyse the impact of a drug on a particular subpopulation without typical privacy and regulatory obstacles. However, the use of synthetic data has yet to be widely adopted due to ongoing technology challenges. In 2021, a Gartner study predicted that 60% of data used for AI and analytics projects would be synthetically generated. The reality is that adoption in healthcare remains low.
What is this page?
You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.
The Privacy Newsfeed monitors over 300 global publications, of which more than 5,750 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.
